Hepatitis B Vaccination in Prison: The Perspectives of Formerly Incarcerated Men

Journal of Correctional Health Care

Volumn 12, Issue 1, 2006, Pages 12-23

  Buck, Jessica M ^a   Morrow, Kathleen M ^b   Margolis, Andrew ^c   Eldridge, Gloria ^d   Sosman, James ^e   MacGowan, Robin ^c   Binson, Diane ^f   Kacanek, Deborah ^g   Flanigan, Timothy P ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b BROWN UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF ALASKA ANCHORAGE   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g TUFTS MEDICAL CENTER   (United States)

Author keywords

correctional health; hepatitis B; prison inmates; vaccine

Indexed keywords

EID: 84997891794     PISSN: 10783458     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078345806287937     Document Type: Article

References (41)

1. Agar, M., & Hobbs, J. R. (1982). Interpreting discourse: Coherence and the analysis of ethnographic interviews. Discourse Processes, 5(1), 1-32.
2. Bayas, J. M., Bruguera, M., Martin, V., Vidal, J., Rodes, J., & Salleras, L. Y. (1993). Hepatitis B vaccination in prisons: The Catalonian experience. Vaccine, 11(14), 1441-1444.
3. Beck, A. J., & Maruschak, L. M. (2004). Hepatitis testing and treatment in state prisons (Bureau of Justice Statistics Special Report, NCJ 199173). Washington, DC: U.S. Department of Justice.
4. Blostein, J., & Clark, P. A. (2001). Cost-effectiveness of preimmunization hepatitis B screening in high-risk adolescents. Public Health Reports, 116(2), 165-168.
5. Butler, T. G., Dolan, K. A., Ferson, M. J., McGuinness, L. M., Brown, P. R., & Robertson, P. W. (1997). Hepatitis B and C in New South Wales prisons: Prevalence and risk factors. Medical Journal of Australia, 166(3), 127-130.
6. Carey, J., & Seal, D. W. (1998). HIV and STD intervention research for young men leaving prison: Training manual for qualitative interviewers. Atlanta, GA: Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention.
7. Charuvastra, A., Stein, J., Schwartzapfel, B., Spaulding, A., Horowitz, E., Macalino, G., et al. (2001). Hepatitis B vaccination practices in state and federal prisons. Public Health Reports, 116(3), 203-209.
8. Croft, N., Stewart, T., Hearne, P., Ping, X. Y., Breshkin, A. M., & Locarnini, S. A. (1995). Spread of bloodborne viruses among Australian prison entrants. BMJ, 310(6975), 285-288.
9. Decker, M. D., Vaughn, W. K., Brodie, J. S., Hutcheson, R. H., Jr., & Schaffner, W. (1984). Seroepidemiology of hepatitis B in Tennessee prisoners. Journal of Infectious Diseases, 150(3), 450-459.
10. Deuson, R. R., Brodovicz, K. G., Barker, L., Zhou, F., & Euler, G. L. (2001). Economic analysis of a child vaccination project among Asian Americans in Philadelphia, Pa. Archives of Pediatrics and Adolescent Medicine, 155(8), 909-914.
11. Ehrhardt, A. A., Fishbein, M., Washington, E., Smith, W., & Holmes, K. K. (1990). The NIAID study group on integrated behavioral research for prevention and control of sexually transmitted diseases. Part II: Issues in designing behavioral interventions. Sexually Transmitted Diseases, 17(4), 204-207.
12. Flanigan, T. P., Rich, J. D., & Spaulding, A. (1999). HIV care among incarcerated persons: A missed opportunity. AIDS, 13(17), 2475-2476.
13. Gaiter, J., & Doll, L. S. (1996). Improving HIV/AIDS prevention in prisons is good public health policy. American Journal of Public Health, 86(9), 1201-1203.
14. Glaser, J. B., & Greifinger, R. B. (1993). Correctional health care: A public health opportunity. Annals of Internal Medicine, 118(2), 139-145.
15. Goldstein, S. T., Alter, M. J., Williams, I. T., Moyer, L. A., Judson, F. N., Mottram, K., et al. (2002). Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: Implications for vaccination programs. Journal of Infectious Diseases, 185(6), 713-719.
16. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. (1999). Morbidity and Mortality Weekly Report, 48(RR-13), 1-27, 29-31.
17. Hall, J. M., & Stevens, P. E. (1991). Rigor in feminist research. ANS Advances in Nursing Science, 13(3), 16-29.
18. Hammett, T. M., Gaiter, J. L., & Crawford, C. (1998). Reaching seriously at-risk populations: Health interventions in criminal justice settings. Health, Education & Behavior, 25(1), 99-120.
19. Hepatitis B outbreak in a state correctional facility, 2000. (2001). Morbidity and Mortality Weekly Report, 50(25), 529-532.
20. Hepatitis B vaccination among high-risk adolescents and adults—San Diego, California, 1998-2001. (2002). Morbidity and Mortality Weekly Report, 51(28), 618-621.
21. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. (1991). Morbidity and Mortality Weekly Report, 40(RR-13), 1-25.
22. Hull, H. F., Lyons, L. H., Mann, J. M., Hadler, S. C., Steece, R., & Skeels, M. R. (1985). Incidence of hepatitis B in the penitentiary of New Mexico. American Journal of Public Health, 75(10), 1213-1214.
23. Inciardi, J. A., McBride, D. C., Platt, J. J., & Baxter, S. (1993). Injection drug users, incarceration, and HIV: Some legal and social service delivery issues. In B. S. Brown & G. M. Beschner (Eds.), Handbook on risk of AIDS injection drug users and sexual partners (pp. 337-351). Westport, CT: Greenwood Press.
24. Koff, R. (1999). Vaccines and hepatitis B. In W. Lee (Ed.), Hepatitis B (pp. 417-428). Philadelphia: W.B. Saunders.
25. Lopez-Zetina, J., Kerndt, P., Ford, W., Woerhle, T., & Weber, M. (2001). Prevalence of HIV and hepatitis B and self-reported injection risk behavior during detention among street-recruited injection drug users in Los Angeles County, 1994-1996. Addiction, 96(4), 589-595.
26. Macalino, G. E., Vlahov, D., Sanford-Colby, S., Patel, S., Sabin, K., Salas, C., et al. (2004). Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. American Journal of Public Health, 94(7), 1218-1223.
27. Mahon, N. (1996). New York inmates' HIV risk behaviors: The implications for prevention policy and programs. American Journal of Public Health, 86(9), 1211-1215.
28. Mast, E. E., Williams, I. T., Alter, M. J., & Margolis, H. S. (1998). Hepatitis B vaccination of adolescent and adult high-risk groups in the United States. Vaccine, 16(Suppl.), S27-S29.
29. McQuillan, G. M., Coleman, P. J., Kruszon-Moran, D., Moyer, L. A., Lambert, S. B., & Margolis, H. S. (1999). Prevalence of hepatitis B virus infection in the United States: The National Health and Nutrition Examination Surveys, 1976 through 1994. American Journal of Public Health, 89(1), 14-18.
30. Mutter, R. C., Grimes, R. M., & Labarthe, D. (1994). Evidence of intraprison spread of HIV infection. Archives of Internal Medicine, 154(7), 793-795.
31. Notice to readers update: Recommendation to prevent hepatitis B virus transmission—United States. (1999). Morbidity and Mortality Weekly Report, 48, 33-34.
32. Pisu, M., Meltzer, M. I., & Lyerla, R. (2002). Cost-effectiveness of hepatitis B vaccination of prison inmates. Vaccine, 21(3-4), 312-321.
33. Rosenthal, S. L., Kottenhahn, R. K., Biro, F. M., & Succop, P. A. (1995). Hepatitis B vaccine acceptance among adolescents and their parents. Journal of Adolescent Health, 17(4), 248-254.
34. Rotily, M., Delorme, C., Galinier, A., Escaffre, N., & Moatti, J. P. (2000). HIV risk behavior in prison and factors associated with reincarceration of injection drug users. La Presse Medicale, 29(28), 1549-1556.
35. Rotily, M., Vernay-Vaisse, C., Bourliere, M., Galinier-Pujol, A., Rousseau, S., & Obadia, Y. (1997). HBV and HIV screening, and hepatitis B immunization programme in the prison of Marseille, France. International Journal of STD and AIDS, 8(12), 753-759.
36. Ruiz, J. D., Chang, J. S., Bernstein, K., Chow, J. M., Bolan, G., Pettifor, A., et al. (2001). Seroprevalence of HIV infection, sexual transmitted diseases, hepatitis, and risk behaviors among inmates entering prison at the California Department of Corrections, 1999. Sacramento, CA: California Department of Health Services.
37. Sexually transmitted diseases treatment guidelines 2002. (2002). Morbidity and Mortality Weekly Report, 51(RR-6), 1-78.
38. Skolnick, A. A. (1998). Look behind bars for key to control of STDs. Journal of the American Medical Association, 279(2), 97-98.
39. Sosman, J. M., MacGowan, R. J., Flanigan, T. P., Vardaman, J., Eldridge, G., Fitzgerald, C., et al. (2001). STD and hepatitis infections, and risk perceptions among 18-29 year old men recently released from prison. Paper presented at the National HIV Prevention Conference, Atlanta, GA.
40. Weinbaum, C., Lyerla, R., & Margolis, H. S. (2003). Prevention and control of infections with hepatitis viruses in correctional settings. Morbidity and Mortality Weekly Report, 52(RR-1), 1-36, quiz CE1-4.
41. Yusuf, H., Daniels, D., Mast, E. E., & Coronado, V. (2001). Hepatitis B vaccination coverage among United States children. Pediatric Infectious Disease Journal, 20(11 Suppl.), S30-S33.